OMCL vs BTSG
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
OMCL · Omnicell$37.34 ▼ 1.81%
BTSG · BrightSpring Health Services$67.15 ▲ 1.96%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- OMCL +1.4%
- BTSG +100.0%
Head to head
| Metric | OMCL | BTSG |
|---|---|---|
| Price | $37.34 | $67.15 |
| Change today | ▼ 1.81% | ▲ 1.96% |
| Market cap | $1.72B | $13.36B |
| Return, 3 months | +0.1% | +9.3% |
| Return, year to date | -17.6% | +79.3% |
| Return, 1 year | +4.7% | +102.6% |
| P/E (TTM) | 38.9 | 36.1 |
| P/B | 1.3 | 6.1 |
| P/E percentile vs own 5y | 35th | 58th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -0.9% | +26.4% |
| Net profit growth (YoY) | +102.2% | +81.6% |
| Gross margin | 45.1% | 12.5% |
| Operating margin | 5.2% | 3.4% |
| Net margin | 3.6% | 2.7% |
| Return on equity | 3.5% | 20.5% |
| Analyst target vs. price | +50.9% | +18.0% |
| Analyst buy share | 83% | 100% |
| RSI (14) | 55 | 60 |
| 30-day volatility | 43.1% | 46.4% |
| Max drawdown, 1 year | -37.3% | -23.6% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- BTSG is the largest of the group by market value.
- BTSG has returned the most over the past year.
- BTSG carries the lowest trailing P/E.
- BTSG is growing revenue fastest.
- OMCL keeps the most profit per dollar of sales.
- OMCL has been the calmest stock over the last 30 days.